rasagiline
Azilect, Rasagiline ratiopharm · ATC code N04BD02
Also known as: Rasagilin · Brand names: Azilect, Rasagiline ratiopharm, Rasigerolan, Rasagea, Asipec, Azılect, Azipar, Aziras, Etkinia, Glarise, Linra, Nervogil, Noparks, Parlin, Rajil …
- Key facts
- Active substance
- rasagiline
- Drug class
- Dopaminergic
- ATC code
- N04BD02
- Authorisation
- centrally authorised across the EU (EMA)
- Dosage forms
- AZILECT 1 mg tablets · Rasagiline ratiopharm 1 mg tablets
- Marketing authorisation holder
- Teva B.V.
- Information as of
- 2026-10-27
Key facts
Rasagiline is a selective, irreversible MAO-B inhibitor. It is used in adults with idiopathic Parkinson's disease as monotherapy or as adjunct to levodopa.
What it is used for
- Idiopathic Parkinson's disease in adults as monotherapy (without levodopa)
- Adjunct to levodopa in patients with end-of-dose fluctuations
Dosing
- 1 mg (one tablet) once daily, with or without levodopa and with or without food
- No dose change in the elderly or in renal impairment
- Mild hepatic impairment: start with caution; moderate: avoid; severe: contraindicated
- Stop if hepatic impairment progresses from mild to moderate
Contraindications
- Hypersensitivity to the active substance or any excipient
- Concomitant other MAO inhibitors (including St John's wort) or pethidine; at least 14 days after stopping rasagiline before starting them
- Severe hepatic impairment
Important warnings
- Avoid fluoxetine or fluvoxamine; wait at least five weeks after stopping fluoxetine
- Dextromethorphan and sympathomimetics (e.g. ephedrine, pseudoephedrine in cold remedies) not recommended
- With levodopa, increased levodopa adverse reactions, dyskinesia and hypotension may occur
- Excessive daytime sleepiness and sudden sleep onset episodes
Side effects
- Monotherapy: headache, depression, vertigo, flu-like symptoms
- With levodopa: dyskinesia, orthostatic hypotension, fall, abdominal pain, nausea, vomiting, dry mouth
- Both: musculoskeletal pain (back, neck), arthralgia
- Hallucinations; skin carcinoma
Interactions
- Other MAO inhibitors: risk of hypertensive crisis – contraindicated
- Pethidine: contraindicated
- Sympathomimetics, dextromethorphan, fluoxetine, fluvoxamine: not recommended or to be avoided
Pregnancy and breastfeeding
- No data in pregnant women; as a precaution, preferable to avoid in pregnancy
- May inhibit prolactin secretion and lactation; caution in breast-feeding
Summary of the official product information, written with AI (Claude, Anthropic) on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Package leaflet, verbatim
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
EU – centrally authorised (all member states)
- AzilectTeva B.V. · EMEA/H/C/000574
- Rasagiline ratiopharmTeva B.V. · EMEA/H/C/003957
- Rasagiline Viatris (previously Rasagiline Mylan) · genericViatris Limited · EMEA/H/C/004064
Source: European Medicines Agency (EMA), product information
Austria
- Rasagilin1a Pharma Gmbh, Accord Healthcare B.V., Bluefish Pharmaceuticals Ab, +pharma Arzneimittel Gmbh, Sandoz Gmbh, Stada Arzneimittel Gmbh, Hcs Bvba · 7 register entries
- RasigerolanG.L. Pharma Gmbh · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Germany
- RasageaTad Pharma Gmbh · 1 register entry
- Rasagilin1 A Pharma Gmbh, Neuraxpharm Arzneimittel Gmbh, Micro Labs Gmbh, Bluefish Pharmaceuticals Ab, Glenmark Arzneimittel Gmbh, Macleods Pharma España, S.L.U, Hormosan Pharma Gmbh, Heumann Pharma Gmbh & Co. Generica Kg, Zentiva Pharma Gmbh, Accord Healthcare B.V., Ascend Gmbh, Axunio Pharma Gmbh, Hexal Ag, Puren Pharma Gmbh & Co. Kg, Betapharm Arzneimittel Gmbh, Abz-Pharma Gmbh, Aliud Pharma Gmbh · 17 register entries
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Turkey
- AsipecTEVA İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- AzılectTEVA PHARMA İLAÇ SAN.VE TİC. A.Ş. · 3 register entries
- AziparALİ RAİF İLAÇ SAN. A.Ş. · 3 register entries
- AzirasHUMANİS SAĞLIK A.Ş. · 4 register entries
- EtkiniaSANTA FARMA İLAÇ SAN. A.Ş. · 4 register entries
- GlarisePLATİN KİMYA MÜMESSİLLİK VE DIŞ TİC. A.Ş. · 1 register entry
- LinraANGELİNİ İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- NervogilİLKO İLAÇ SAN.VE TİC. A.Ş. · 1 register entry
- NoparksDİNÇSA İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- ParlinNOBEL İLAÇ PAZARLAMA VE SAN. LTD. ŞTİ. · 1 register entry
- RajilGENVEON İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- RasalasABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş. · 3 register entries
Show all 14 brand names
- SaglisNOBEL İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- TreparBİOFARMA İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16
Brand names in 28 more European countries
- Belgium
- Rasagiline Eg, Rasagiline Krka, Rasagiline Teva
- Bulgaria
- Ралаго, Сагилия
- Croatia
- Azipron, Ralago, Razagilin Belupo, Razagilin Makpharm, Razagilin Stada, Sagilia
- Cyprus
- Azipron, Rasagiline Krka, Sagilia, Tivel
- Czechia
- Detreman, Ralago, Sagilia
- Denmark
- Rasagilin Accord, Rasagilin Glenmark, Rasagilin Krka, Rasagilin Stada
- Estonia
- Ralago, Sagilia
- Finland
- Rasabon, Rasagilin, Rasagiline Accord
- France
- Rasagiline Accord, Rasagiline Arrow, Rasagiline Biogaran, Rasagiline Cristers, Rasagiline Eg, Rasagiline Farmalider, Rasagiline Krka, Rasagiline Sandoz, Rasagiline Zentiva, Rasagiline Zydus
- Greece
- Asarkin, Ractilen, Ralago, Ranzal, Rasagiline Ariti, Rasagiline Genepharm, Sagilia
- Hungary
- Ralago, Rasagiline Stada, Rasilin, Razagilin Q Pharma, Razagilin Sandoz
- Iceland
- Azilect, Rasagilin Krka, Rasagiline Ratiopharm, Rasagiline Viatris
- Ireland
- Rasagiline Accord, Rasagiline Clonmel, Rasagiline Krka, Rasagiline Rowex, Rasagiline Teva
- Italy
- Aidex, Rasabon, Rasagilina Accord, Rasagilina Aurobindo, Rasagilina Doc Generici, Rasagilina Eg, Rasagilina Krka, Rasagilina Sandoz, Rasagilina Teva, Rasaral
- Latvia
- Ralago
- Liechtenstein
- Azilect, Rasagiline Ratiopharm, Rasagiline Viatris
- Lithuania
- Ralago, Rasagiline Sandoz, Sagilia
- Luxembourg
- Rasagilin Micro Labs, Rasagiline Eg
- Malta
- Rasagiline Ascend, Sagilia
- Netherlands
- Rasagiline Aurobindo, Rasagiline Bioorganics, Rasagiline Cf, Rasagiline Doc Generici, Rasagiline Krka, Rasagiline Sandoz, Rasagiline Synthon
- Norway
- Azilect, Rasagilin Accord, Rasagilin Krka, Rasagiline Ratiopharm, Rasagiline Viatris
- Poland
- Asanix, Ralago, Rasagilina Synthon, Rasagiline Accord
- Portugal
- Detreman, Rasagilina Alras Alter, Rasagilina Alter, Rasagilina Aurovitas, Rasagilina Biofarmoz, Rasagilina Bluepharma, Rasagilina Ciclum, Rasagilina Farmoz, Rasagilina Generis, Rasagilina Gp, Rasagilina Krka, Rasagilina Maxmind, Rasagilina Pentafarma, Rasagilina Pharmakern, Rasagilina Sandoz, Rasagilina Tolife, Rasagilina Zentiva, Rasat
- Romania
- Hiperavia, Sagilia
- Slovakia
- Ralago, Rasagiline Egis, Rasagiline Sandoz, Rasagiline Stada, Rasigerolan, Sagilia
- Slovenia
- Ralago, Razagilin Krka, Razagilin Sandoz, Razagilin Stada
- Spain
- Altina, Neuromiol, Raglysa, Rasagilina Alter, Rasagilina Aurovitas Spain, Rasagilina Bluefish, Rasagilina Cinfa, Rasagilina Cinfamed, Rasagilina Combix, Rasagilina Efarmes, Rasagilina Ferrer, Rasagilina Kern Pharma, Rasagilina Krka, Rasagilina Mabo, Rasagilina Normon, Rasagilina Pharmakern, Rasagilina Qualigen, Rasagilina Ratio, Rasagilina Sandoz, Rasagilina Stada, Rasagilina Tecnigen, Rasagilina Teva-Ratio, Rasagilina Viso Farmacéutica
- Sweden
- Rasagilin Glenmark, Rasagilin Krka, Rasagilin Stada, Rasagiline Accord, Rasagiline Bluefish, Rasagiline Ratio, Rasagiline Teva
EMA – Article 57 product data (EU/EEA), 2026-10-28
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- European Medicines Agency. Azilect – EPAR, Product Information (OF THE TEXT Detailed information on this product is availabl). 2026-10-27. https://www.ema.europa.eu/en/documents/product-information/azilect-epar-product-information_en.pdf
- European Medicines Agency. Rasagiline ratiopharm – EPAR, Product Information (OF THE TEXT MM/YYYY Detailed information on this product is ). 2026-10-27. https://www.ema.europa.eu/en/documents/product-information/rasagiline-ratiopharm-epar-product-information_en.pdf
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
- Wikidata (CC0): ATC N04BD.
Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error
Source: European Medicines Agency (EMA), product information. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.